Cargando…

Response to comment on “New therapeutic agents in diabetic nephropathy”

Detalles Bibliográficos
Autores principales:	Kim, Yaeni, Park, Cheol Whee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432813/ https://www.ncbi.nlm.nih.gov/pubmed/28490721 http://dx.doi.org/10.3904/kjim.2017.154

Ejemplares similares

New therapeutic agents in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2017)

Comment on “New therapeutic agents in diabetic nephropathy”
por: Gay, Alain, et al.
Publicado: (2017)

Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016)

Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
por: Kim, Yaeni, et al.
Publicado: (2019)

Can management of the components of metabolic syndrome modify the course of chronic kidney disease?
por: Kim, Yaeni, et al.
Publicado: (2020)

Attenuated Lymphatic Proliferation Ameliorates Diabetic Nephropathy and High-Fat Diet-Induced Renal Lipotoxicity
por: Kim, Yaeni, et al.
Publicado: (2019)

Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?
por: Park, Cheol Whee
Publicado: (2013)

Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
por: Chung, Sungjin, et al.
Publicado: (2011)

Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
por: Park, Hoon Suk, et al.
Publicado: (2016)

Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db/db mice
por: Hwang, Seun Deuk, et al.
Publicado: (2019)

Erratum to: Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
por: Park, Hoon Suk, et al.
Publicado: (2016)

Hot Weather and Therapeutic Agents: Response to Arya
por: Smoyer-Tomic, KE
Publicado: (2002)

Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy
por: Kim, Yaeni, et al.
Publicado: (2019)

Response to ‘Comment on: ‘A new era for giant cell arteritis’’
por: Mollan, S. P., et al.
Publicado: (2019)

Renal hypouricemia as the cause of exercise-induced acute kidney injury
por: Lee, Haeun, et al.
Publicado: (2023)

Vascular Endothelial Growth Factor-Receptor 1 Inhibition Aggravates Diabetic Nephropathy through eNOS Signaling Pathway in db/db Mice
por: Yang, Keun Suk, et al.
Publicado: (2014)

Response to the comment of Perone by the corresponding author Kim
por: Kim, Yongmoon, et al.
Publicado: (2023)

Identification of Transcription Regulatory Relationships in Diabetic Nephropathy
por: Shi, Jing-Song, et al.
Publicado: (2018)

Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy
por: Lim, Ji Hee, et al.
Publicado: (2018)

Response to comment by Moxon et al.
por: Thompson, Dawn, et al.
Publicado: (2018)

Response to comment by Guerra et al.
por: Yang, Xinyue, et al.
Publicado: (2018)

Response to comment from Brasky et al.
por: Verdoodt, F., et al.
Publicado: (2016)

Snake Venom as a Therapeutic Agent
por: Balfour, Andrew
Publicado: (1920)

Comment on: ‘A new era for giant cell arteritis’
por: Ing, Edsel
Publicado: (2019)

Response to comment on “Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception”
por: Suh, Young Sun, et al.
Publicado: (2018)

Comment on: Evaluation of early biomarkers of renal dysfunction in diabetic patients
por: Alsaeed, Abdulghani H.
Publicado: (2020)

Comments on: “Asymptomatic abdominal wall and incisional hernias: Is therapeutic decision consensual? An international survey”
por: Kalipershad, Sujala N.R.
Publicado: (2021)

Comment on “Diversity Outbred: A New Generation of Mouse Model”
por: Erren, Thomas C., et al.
Publicado: (2015)

Comment on: Fracture risk assessment in patients with type 2 diabetes mellitus
por: Jawad, Ali S.
Publicado: (2022)

Response to ‘Comment on: ophthalmology specialist trainee survey in the United Kingdom’
por: Dean, William H., et al.
Publicado: (2019)

The Author's Response: Response to the Comment: Chest Compression Rate, Rescuer's Fatigue and Patient's Survival
por: Hwang, Sung Oh
Publicado: (2016)

READERS COMMENTS
por: Skaik, Younis Abed El-Wahhab
Publicado: (2011)

Response to “Comment on ‘Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology’”
por: Calafat, Antonia M., et al.
Publicado: (2016)

Response to “Comment on ‘Predictors of Indoor Radon Concentrations in Pennsylvania, 1989–2013’”
por: Casey, Joan A., et al.
Publicado: (2015)

Response to Comment on: Sector retinitis pigmentosa caused by mutations of the RHO gene
por: Xiao, Ting, et al.
Publicado: (2019)

Role of AYUSH doctors in rural healthcare: Authors’ responses to critical comments
por: Chandra, Shailaja, et al.
Publicado: (2019)

Membranous Nephropathy Associated with Tuberculosis
por: Shang, Ming-Hua, et al.
Publicado: (2016)

Comment on “On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens”
por: Houck, Keith A., et al.
Publicado: (2017)

Comment on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’
por: Wang, Yao, et al.
Publicado: (2023)

Calcimimetic restores diabetic peripheral neuropathy by ameliorating apoptosis and improving autophagy
por: Chung, You Chul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8eeh8d8p834kloig7ov6ihj3kl